BRIEF—Lilly appoints new VP of early phase development and immuno-oncology

Eli Lilly has appointed Kimberly Blackwell as vice president of early phase development and immuno-oncology.

Dr Blackwell is currently professor of medicine and assistant professor of radiation oncology at Duke University Medical Center.

"We are pleased and honored to welcome Dr Blackwell to Lilly," said Sue Mahony, senior vice president and president of Lilly Oncology.

"She is highly regarded for her leadership in cancer research, especially metastatic breast cancer."

"Furthermore, she has been on the forefront of research in oncology vaccines, immuno-oncology and biosimilars."